NEO
Neogenomics Inc.

2,852
Mkt Cap
$1.62B
Volume
527,001.00
52W High
$16.18
52W Low
$4.72
PE Ratio
-14.07
NEO Fundamentals
Price
$12.89
Prev Close
$12.49
Open
$12.71
50D MA
$11.48
Beta
1.45
Avg. Volume
1.6M
EPS (Annual)
-$0.6216
P/B
1.92
Rev/Employee
$300,257.27
News
all
press releases
NeoGenomics (NASDAQ:NEO) Shares Down 7.4% - Here's What Happened
NeoGenomics (NASDAQ:NEO) Stock Price Down 7.4% - What's Next...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
NeoGenomics (NASDAQ:NEO) Earns "Buy" Rating from Needham & Company LLC
Needham & Company LLC reaffirmed a "buy" rating and set a $14.00 target price on shares of NeoGenomics in a report on Monday...
MarketBeat·1d ago
News Placeholder
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced preliminary fourth quarter and full-year 2025 revenue and also...
Business Wire·1d ago
News Placeholder
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the upcoming 44th Annual J.P...
Business Wire·8d ago
News Placeholder
NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Hold" by Analysts
NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has been given a consensus rating of "Hold" by the fifteen analysts that are currently covering the company, Marketbeat reports. One investment...
MarketBeat·9d ago
News Placeholder
HighMark Wealth Management LLC Has $3.09 Million Position in NeoGenomics, Inc. $NEO
HighMark Wealth Management LLC boosted its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 221.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·12d ago
News Placeholder
Ryvyl, NeoGenomics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
read more...
Benzinga·14d ago
News Placeholder
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. Jack Kenny to its Board of Directors
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the appointment of diagnostics and lab services industry veteran...
Business Wire·14d ago
News Placeholder
NeoGenomics, Inc. $NEO Shares Sold by Kopp Family Office LLC
Kopp Family Office LLC reduced its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 43.1% in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·17d ago
News Placeholder
NeoGenomics, Inc. $NEO Shares Acquired by Squarepoint Ops LLC
Squarepoint Ops LLC grew its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 246.8% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 735,473...
MarketBeat·29d ago
<
1
2
...
>

Latest NEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.